Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia Terminated Phase 1 / 2 Trials for Imatinib (DB00619)

IndicationStatusPhase
DBCOND0029916 (Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia)Terminated1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01383447Entinostat And Imatinib Mesylate In Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaTreatment